Douglas E Coltharp

CFO Douglas E Coltharp sells 27,694 shares at $106.83 for $2,958,550.47; retains 69,377 shares in EHC.

Douglas E Coltharp, EVP & Chief Financial Officer of Encompass Health Corp, executed 2 separate sales totaling 27,694 shares for $2,958,550.47 at a blended average price of $106.83. The reduction represents a -28.5% decrease in his holdings, leaving him with 69,377 shares post-transaction. The current stock price of $106.96 is -16.4% from the 52-week high of $127.99, and over his prior 5 trades at EHC, 3 of 5 same-ticker sells were well-timed (negative 90-day returns), though the most recent April 2025 tranche showed mixed near-term results (+3.1% to +4.6% at 30 days) before declining at the 90-day horizon. With the company reporting $1.6B in quarterly revenue, +10.5% annual growth, and a P/E of 17.42, the fundamentals remain intact, though the significant share reduction warrants monitoring of his forward outlook.

CFO Coltharp sells 43,575 shares of EHC for $5,017,537.68, reducing holdings 41.9%, near 52-week high of $116.99

CFO Douglas Coltharp executed 3 separate sales on 2025-04-29, selling a total of 43,575 shares (43.6K shares) at prices ranging from $114.78 to $116.36 (blended average $115.15) for $5,017,537.68 ($5.0M), reducing his holdings by 41.9% from 103,910 to 60,335 shares. The sales occurred at prices near the stock's 52-week high of $116.99, with the current price at that level. His prior two measurable sales at EHC (2024-08-13) produced 90-day returns of +19.6% and +18.7%, indicating the stock rose after those sales—a poorly-timed outcome by the 0 of 2 well-timed rate metric. The company shows solid fundamentals with annual revenue growth of +11.9% and a P/E of 22.41, though the stock has appreciated +15.5% over the past 30 days and +18.9% over 90 days, reflecting strong recent momentum at the time of this substantial equity reduction.

CFO Coltharp sells 12,260 shares of EHC at $86.34 blended price for $1.1M; prior EHC sale in Nov 2023 saw 90-day stock rise

Douglas E. Coltharp, EVP & Chief Financial Officer, executed 2 separate sales totaling 12,260 shares on 2024-08-13 for $1,058,474.40 at a blended average price of $86.34, reducing his holdings from 148,487 to 136,227 shares (an 8.3% reduction). At the same-ticker level, his only prior EHC trade was a sale on 2023-11-13, which was followed by a 90-day return of +15.0%, meaning the stock rose after that insider sale rather than fell. The current stock price of $86.98 sits 6.5% below the 52-week high of $93.02, with the company posting strong recent fundamentals (FY revenue growth of +10.4%, P/E of 21.91). The timing pattern at EHC offers no signal of predictive accuracy: his 1 prior sale at this ticker resulted in a gain for equity holders, not a loss that would suggest prescient insider selling.